Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Journal of the Neurological Sciences

Volumn 142, Issue 1-2, 1996, Pages 65-69

  Fujihara, Kazuo ^a,b   Itoyama, Yasuto ^a,b   Yu, Feng ^a,c   Kubo, Chiharu ^d   Goto, Ikuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

ADCC; cytotoxicity; HAM; host defense; HTLV I; immune surveillance; retrovirus; TSP

Indexed keywords

ADULT; AGED; ARTICLE; CELL MEDIATED CYTOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MALE; PRIORITY JOURNAL; SPASTIC PARESIS; SPINAL CORD DISEASE;

EID: 0030271548     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00149-9     Document Type: Article

References (16)

1. Cruse JM, et al. (1993) Decreased immune reactivity and neuroendocrine alterations related to chronic stress in spinal cord injury and stroke patients. Pathobiology, 61: 183-192.
2. Gessain A, et al. (1985) Antibodies to human T-cell lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet, 2: 407-409.
3. Itoyama Y, et al. (1988) Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology, 38: 1302-1307.
4. Jacobson S, et al. (1990) Immunological studies in tropical spastic paraparesis. Ann. Neurol., 27: 149-156.
5. Kaplan JE, et al. (1990) The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J. Acquired Immunodef. Synd., 3: 1096-1101.
6. Katz JD, et al. (1987) Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDs-related complex. II: Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity. J. Immunol. 139: 55-60.
7. Kira J-i, et al. (1991) Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: A quantitative polymerase chain reaction study. Ann. Neurol., 29: 194-201.
8. tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: Correlation with increased HTLV-I proviral DNA load. J. Neurol. Sci., 107: 98-104.
9. Koyanagi Y, et al. (1993) In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology, 196: 25-33.
10. Kozuru M, et al. (1989) The possible mode of escape of adult T-cell leukemia cells from antibody-dependent cellular cytotoxicity. Br. J. Haematol., 72: 502-506.
11. Miyakoshi H, et al. (1984) In vivo antibody-dependent cellular cytotoxicity against human T-cell leukemia lymphoma virus (HTLV)-producing cells. Int. J. Cancer, 33: 287-291.
12. Osame M, et al. (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet, 1: 1031-1032.
13. Tendler CL, et al. (1991) Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis. J. Cell Biochem., 46: 302-311.
14. Yoshida M, et al. (1989) Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann. Neurol., 26: 331-335.
15. Yu F, et al. (1991) Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesis - decrease in NK cell subset populations in HTLV-I seropositive individuals. J. Neuroimmunol., 33: 121-128.
16. Zhang X, et al. (1992) Human T lymphotropic virus types I-and II-specific antibody-dependent cellular cytotoxicity: Strain specificity and epitope mapping. J. Infect. Dis., 165: 805-812.